aluates Reports

$ 0.0

Automative

Global Lung Cancer Liquid Biops Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-35Z1721

Global Lung Cancer Liquid Biops Market Insights and Forecast to 2028

BUY CHAPTERS

Global Lung Cancer Liquid Biops Market Research Report 2025

Code: QYRE-Auto-35Z1721

Report

September 2025

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biocept

EntroGen

Cynvenio Biosystems

Exosome Diagnostics

F.Hoffmann-La Roche

Clearbridge Biomedics

Bio Rad Laboratories

Agena Bioscience

Cancer Genetics

CellMax Life

Nateras

MedGenome

OncoDNA

Genomic Health

Trovagene

Fluxion Biosciences

Biodesix

Epic Sciences

Shuwen Biotech

Personal Genome Diagnostics

Predicine

Lung Cancer Liquid Biops Market Size

The global market for Lung Cancer Liquid Biops was valued at US$ 555 million in the year 2024 and is projected to reach a revised size of US$ 1372 million by 2031, growing at a CAGR of 14.0% during the forecast period.

Lung Cancer Liquid Biops Market

North American market for Lung Cancer Liquid Biops is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lung Cancer Liquid Biops is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Lung Cancer Liquid Biops in Hospitals and Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Lung Cancer Liquid Biops include Biocept, EntroGen, Cynvenio Biosystems, Exosome Diagnostics, F. Hoffmann-La Roche, Clearbridge BioMedics, Bio-Rad Laboratories, Agena Bioscience, Cancer Genetics, CellMax Life, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Liquid Biops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Liquid Biops.

The Lung Cancer Liquid Biops market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer Liquid Biops market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Liquid Biops companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Liquid Biops Market Report

Report Metric	Details
Report Name	Lung Cancer Liquid Biops Market
Accounted market size in year	US$ 555 million
Forecasted market size in 2031	US$ 1372 million
CAGR	14.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Exosomes and RNA CTCs and ctDNA
Segment by Application	Hospitals and Clinics Physicians'Office Laboratories Clinical Diagnostic Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biocept, EntroGen, Cynvenio Biosystems, Exosome Diagnostics, F. Hoffmann-La Roche, Clearbridge BioMedics, Bio-Rad Laboratories, Agena Bioscience, Cancer Genetics, CellMax Life, Nateras, MedGenome, OncoDNA, Genomic Health, Trovagene, Fluxion Biosciences, Biodesix, Epic Sciences, Shuwen Biotech, Personal Genome Diagnostics, Predicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Liquid Biops company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lung Cancer Liquid Biops Market growing?

Ans: The Lung Cancer Liquid Biops Market witnessing a CAGR of 14.0% during the forecast period 2025-2031.

What is the Lung Cancer Liquid Biops Market size in 2031?

Ans: The Lung Cancer Liquid Biops Market size in 2031 will be US$ 1372 million.

Who are the main players in the Lung Cancer Liquid Biops Market report?

Ans: The main players in the Lung Cancer Liquid Biops Market are Biocept, EntroGen, Cynvenio Biosystems, Exosome Diagnostics, F. Hoffmann-La Roche, Clearbridge BioMedics, Bio-Rad Laboratories, Agena Bioscience, Cancer Genetics, CellMax Life, Nateras, MedGenome, OncoDNA, Genomic Health, Trovagene, Fluxion Biosciences, Biodesix, Epic Sciences, Shuwen Biotech, Personal Genome Diagnostics, Predicine

What are the Application segmentation covered in the Lung Cancer Liquid Biops Market report?

Ans: The Applications covered in the Lung Cancer Liquid Biops Market report are Hospitals and Clinics, Physicians'Office Laboratories, Clinical Diagnostic Laboratories

What are the Type segmentation covered in the Lung Cancer Liquid Biops Market report?

Ans: The Types covered in the Lung Cancer Liquid Biops Market report are Exosomes and RNA, CTCs and ctDNA

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Liquid Biops Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Exosomes and RNA

1.2.3 CTCs and ctDNA

1.3 Market by Application

1.3.1 Global Lung Cancer Liquid Biops Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals and Clinics

1.3.3 Physicians'Office Laboratories

1.3.4 Clinical Diagnostic Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Liquid Biops Market Perspective (2020-2031)

2.2 Global Lung Cancer Liquid Biops Growth Trends by Region

2.2.1 Global Lung Cancer Liquid Biops Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lung Cancer Liquid Biops Historic Market Size by Region (2020-2025)

2.2.3 Lung Cancer Liquid Biops Forecasted Market Size by Region (2026-2031)

2.3 Lung Cancer Liquid Biops Market Dynamics

2.3.1 Lung Cancer Liquid Biops Industry Trends

2.3.2 Lung Cancer Liquid Biops Market Drivers

2.3.3 Lung Cancer Liquid Biops Market Challenges

2.3.4 Lung Cancer Liquid Biops Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Liquid Biops Players by Revenue

3.1.1 Global Top Lung Cancer Liquid Biops Players by Revenue (2020-2025)

3.1.2 Global Lung Cancer Liquid Biops Revenue Market Share by Players (2020-2025)

3.2 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lung Cancer Liquid Biops Revenue

3.4 Global Lung Cancer Liquid Biops Market Concentration Ratio

3.4.1 Global Lung Cancer Liquid Biops Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Liquid Biops Revenue in 2024

3.5 Global Key Players of Lung Cancer Liquid Biops Head office and Area Served

3.6 Global Key Players of Lung Cancer Liquid Biops, Product and Application

3.7 Global Key Players of Lung Cancer Liquid Biops, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Liquid Biops Breakdown Data by Type

4.1 Global Lung Cancer Liquid Biops Historic Market Size by Type (2020-2025)

4.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2026-2031)

5 Lung Cancer Liquid Biops Breakdown Data by Application

5.1 Global Lung Cancer Liquid Biops Historic Market Size by Application (2020-2025)

5.2 Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lung Cancer Liquid Biops Market Size (2020-2031)

6.2 North America Lung Cancer Liquid Biops Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lung Cancer Liquid Biops Market Size by Country (2020-2025)

6.4 North America Lung Cancer Liquid Biops Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Liquid Biops Market Size (2020-2031)

7.2 Europe Lung Cancer Liquid Biops Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lung Cancer Liquid Biops Market Size by Country (2020-2025)

7.4 Europe Lung Cancer Liquid Biops Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Liquid Biops Market Size (2020-2031)

8.2 Asia-Pacific Lung Cancer Liquid Biops Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2020-2025)

8.4 Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Liquid Biops Market Size (2020-2031)

9.2 Latin America Lung Cancer Liquid Biops Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lung Cancer Liquid Biops Market Size by Country (2020-2025)

9.4 Latin America Lung Cancer Liquid Biops Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Liquid Biops Market Size (2020-2031)

10.2 Middle East & Africa Lung Cancer Liquid Biops Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2020-2025)

10.4 Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biocept

11.1.1 Biocept Company Details

11.1.2 Biocept Business Overview

11.1.3 Biocept Lung Cancer Liquid Biops Introduction

11.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.1.5 Biocept Recent Development

11.2 EntroGen

11.2.1 EntroGen Company Details

11.2.2 EntroGen Business Overview

11.2.3 EntroGen Lung Cancer Liquid Biops Introduction

11.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.2.5 EntroGen Recent Development

11.3 Cynvenio Biosystems

11.3.1 Cynvenio Biosystems Company Details

11.3.2 Cynvenio Biosystems Business Overview

11.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction

11.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.3.5 Cynvenio Biosystems Recent Development

11.4 Exosome Diagnostics

11.4.1 Exosome Diagnostics Company Details

11.4.2 Exosome Diagnostics Business Overview

11.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction

11.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.4.5 Exosome Diagnostics Recent Development

11.5 F. Hoffmann-La Roche

11.5.1 F. Hoffmann-La Roche Company Details

11.5.2 F. Hoffmann-La Roche Business Overview

11.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction

11.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.5.5 F. Hoffmann-La Roche Recent Development

11.6 Clearbridge BioMedics

11.6.1 Clearbridge BioMedics Company Details

11.6.2 Clearbridge BioMedics Business Overview

11.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction

11.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.6.5 Clearbridge BioMedics Recent Development

11.7 Bio-Rad Laboratories

11.7.1 Bio-Rad Laboratories Company Details

11.7.2 Bio-Rad Laboratories Business Overview

11.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction

11.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.7.5 Bio-Rad Laboratories Recent Development

11.8 Agena Bioscience

11.8.1 Agena Bioscience Company Details

11.8.2 Agena Bioscience Business Overview

11.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction

11.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.8.5 Agena Bioscience Recent Development

11.9 Cancer Genetics

11.9.1 Cancer Genetics Company Details

11.9.2 Cancer Genetics Business Overview

11.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction

11.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.9.5 Cancer Genetics Recent Development

11.10 CellMax Life

11.10.1 CellMax Life Company Details

11.10.2 CellMax Life Business Overview

11.10.3 CellMax Life Lung Cancer Liquid Biops Introduction

11.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.10.5 CellMax Life Recent Development

11.11 Nateras

11.11.1 Nateras Company Details

11.11.2 Nateras Business Overview

11.11.3 Nateras Lung Cancer Liquid Biops Introduction

11.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.11.5 Nateras Recent Development

11.12 MedGenome

11.12.1 MedGenome Company Details

11.12.2 MedGenome Business Overview

11.12.3 MedGenome Lung Cancer Liquid Biops Introduction

11.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.12.5 MedGenome Recent Development

11.13 OncoDNA

11.13.1 OncoDNA Company Details

11.13.2 OncoDNA Business Overview

11.13.3 OncoDNA Lung Cancer Liquid Biops Introduction

11.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.13.5 OncoDNA Recent Development

11.14 Genomic Health

11.14.1 Genomic Health Company Details

11.14.2 Genomic Health Business Overview

11.14.3 Genomic Health Lung Cancer Liquid Biops Introduction

11.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.14.5 Genomic Health Recent Development

11.15 Trovagene

11.15.1 Trovagene Company Details

11.15.2 Trovagene Business Overview

11.15.3 Trovagene Lung Cancer Liquid Biops Introduction

11.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.15.5 Trovagene Recent Development

11.16 Fluxion Biosciences

11.16.1 Fluxion Biosciences Company Details

11.16.2 Fluxion Biosciences Business Overview

11.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction

11.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.16.5 Fluxion Biosciences Recent Development

11.17 Biodesix

11.17.1 Biodesix Company Details

11.17.2 Biodesix Business Overview

11.17.3 Biodesix Lung Cancer Liquid Biops Introduction

11.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.17.5 Biodesix Recent Development

11.18 Epic Sciences

11.18.1 Epic Sciences Company Details

11.18.2 Epic Sciences Business Overview

11.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction

11.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.18.5 Epic Sciences Recent Development

11.19 Shuwen Biotech

11.19.1 Shuwen Biotech Company Details

11.19.2 Shuwen Biotech Business Overview

11.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction

11.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.19.5 Shuwen Biotech Recent Development

11.20 Personal Genome Diagnostics

11.20.1 Personal Genome Diagnostics Company Details

11.20.2 Personal Genome Diagnostics Business Overview

11.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction

11.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.20.5 Personal Genome Diagnostics Recent Development

11.21 Predicine

11.21.1 Predicine Company Details

11.21.2 Predicine Business Overview

11.21.3 Predicine Lung Cancer Liquid Biops Introduction

11.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2020-2025)

11.21.5 Predicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Biocept

EntroGen

Cynvenio Biosystems

Exosome Diagnostics

F.Hoffmann-La Roche

Clearbridge Biomedics

Bio Rad Laboratories

Agena Bioscience

Cancer Genetics

CellMax Life

Nateras

MedGenome

OncoDNA

Genomic Health

Trovagene

Fluxion Biosciences

Biodesix

Epic Sciences

Shuwen Biotech

Personal Genome Diagnostics

Predicine

List of Tables

Table 1. Global Lung Cancer Liquid Biops Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Exosomes and RNA

Table 3. Key Players of CTCs and ctDNA

Table 4. Global Lung Cancer Liquid Biops Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Lung Cancer Liquid Biops Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Lung Cancer Liquid Biops Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Lung Cancer Liquid Biops Market Share by Region (2020-2025)

Table 8. Global Lung Cancer Liquid Biops Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Lung Cancer Liquid Biops Market Share by Region (2026-2031)

Table 10. Lung Cancer Liquid Biops Market Trends

Table 11. Lung Cancer Liquid Biops Market Drivers

Table 12. Lung Cancer Liquid Biops Market Challenges

Table 13. Lung Cancer Liquid Biops Market Restraints

Table 14. Global Lung Cancer Liquid Biops Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Lung Cancer Liquid Biops Market Share by Players (2020-2025)

Table 16. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2024)

Table 17. Ranking of Global Top Lung Cancer Liquid Biops Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Lung Cancer Liquid Biops Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Lung Cancer Liquid Biops, Headquarters and Area Served

Table 20. Global Key Players of Lung Cancer Liquid Biops, Product and Application

Table 21. Global Key Players of Lung Cancer Liquid Biops, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Lung Cancer Liquid Biops Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2020-2025)

Table 25. Global Lung Cancer Liquid Biops Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Lung Cancer Liquid Biops Revenue Market Share by Type (2026-2031)

Table 27. Global Lung Cancer Liquid Biops Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2020-2025)

Table 29. Global Lung Cancer Liquid Biops Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Lung Cancer Liquid Biops Revenue Market Share by Application (2026-2031)

Table 31. North America Lung Cancer Liquid Biops Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Lung Cancer Liquid Biops Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Lung Cancer Liquid Biops Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Lung Cancer Liquid Biops Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Lung Cancer Liquid Biops Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Lung Cancer Liquid Biops Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Lung Cancer Liquid Biops Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Lung Cancer Liquid Biops Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Lung Cancer Liquid Biops Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Lung Cancer Liquid Biops Market Size by Country (2026-2031) & (US$ Million)

Table 46. Biocept Company Details

Table 47. Biocept Business Overview

Table 48. Biocept Lung Cancer Liquid Biops Product

Table 49. Biocept Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 50. Biocept Recent Development

Table 51. EntroGen Company Details

Table 52. EntroGen Business Overview

Table 53. EntroGen Lung Cancer Liquid Biops Product

Table 54. EntroGen Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 55. EntroGen Recent Development

Table 56. Cynvenio Biosystems Company Details

Table 57. Cynvenio Biosystems Business Overview

Table 58. Cynvenio Biosystems Lung Cancer Liquid Biops Product

Table 59. Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 60. Cynvenio Biosystems Recent Development

Table 61. Exosome Diagnostics Company Details

Table 62. Exosome Diagnostics Business Overview

Table 63. Exosome Diagnostics Lung Cancer Liquid Biops Product

Table 64. Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 65. Exosome Diagnostics Recent Development

Table 66. F. Hoffmann-La Roche Company Details

Table 67. F. Hoffmann-La Roche Business Overview

Table 68. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product

Table 69. F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 70. F. Hoffmann-La Roche Recent Development

Table 71. Clearbridge BioMedics Company Details

Table 72. Clearbridge BioMedics Business Overview

Table 73. Clearbridge BioMedics Lung Cancer Liquid Biops Product

Table 74. Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 75. Clearbridge BioMedics Recent Development

Table 76. Bio-Rad Laboratories Company Details

Table 77. Bio-Rad Laboratories Business Overview

Table 78. Bio-Rad Laboratories Lung Cancer Liquid Biops Product

Table 79. Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 80. Bio-Rad Laboratories Recent Development

Table 81. Agena Bioscience Company Details

Table 82. Agena Bioscience Business Overview

Table 83. Agena Bioscience Lung Cancer Liquid Biops Product

Table 84. Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 85. Agena Bioscience Recent Development

Table 86. Cancer Genetics Company Details

Table 87. Cancer Genetics Business Overview

Table 88. Cancer Genetics Lung Cancer Liquid Biops Product

Table 89. Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 90. Cancer Genetics Recent Development

Table 91. CellMax Life Company Details

Table 92. CellMax Life Business Overview

Table 93. CellMax Life Lung Cancer Liquid Biops Product

Table 94. CellMax Life Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 95. CellMax Life Recent Development

Table 96. Nateras Company Details

Table 97. Nateras Business Overview

Table 98. Nateras Lung Cancer Liquid Biops Product

Table 99. Nateras Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 100. Nateras Recent Development

Table 101. MedGenome Company Details

Table 102. MedGenome Business Overview

Table 103. MedGenome Lung Cancer Liquid Biops Product

Table 104. MedGenome Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 105. MedGenome Recent Development

Table 106. OncoDNA Company Details

Table 107. OncoDNA Business Overview

Table 108. OncoDNA Lung Cancer Liquid Biops Product

Table 109. OncoDNA Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 110. OncoDNA Recent Development

Table 111. Genomic Health Company Details

Table 112. Genomic Health Business Overview

Table 113. Genomic Health Lung Cancer Liquid Biops Product

Table 114. Genomic Health Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 115. Genomic Health Recent Development

Table 116. Trovagene Company Details

Table 117. Trovagene Business Overview

Table 118. Trovagene Lung Cancer Liquid Biops Product

Table 119. Trovagene Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 120. Trovagene Recent Development

Table 121. Fluxion Biosciences Company Details

Table 122. Fluxion Biosciences Business Overview

Table 123. Fluxion Biosciences Lung Cancer Liquid Biops Product

Table 124. Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 125. Fluxion Biosciences Recent Development

Table 126. Biodesix Company Details

Table 127. Biodesix Business Overview

Table 128. Biodesix Lung Cancer Liquid Biops Product

Table 129. Biodesix Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 130. Biodesix Recent Development

Table 131. Epic Sciences Company Details

Table 132. Epic Sciences Business Overview

Table 133. Epic Sciences Lung Cancer Liquid Biops Product

Table 134. Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 135. Epic Sciences Recent Development

Table 136. Shuwen Biotech Company Details

Table 137. Shuwen Biotech Business Overview

Table 138. Shuwen Biotech Lung Cancer Liquid Biops Product

Table 139. Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 140. Shuwen Biotech Recent Development

Table 141. Personal Genome Diagnostics Company Details

Table 142. Personal Genome Diagnostics Business Overview

Table 143. Personal Genome Diagnostics Lung Cancer Liquid Biops Product

Table 144. Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 145. Personal Genome Diagnostics Recent Development

Table 146. Predicine Company Details

Table 147. Predicine Business Overview

Table 148. Predicine Lung Cancer Liquid Biops Product

Table 149. Predicine Revenue in Lung Cancer Liquid Biops Business (2020-2025) & (US$ Million)

Table 150. Predicine Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Lung Cancer Liquid Biops Picture

Figure 2. Global Lung Cancer Liquid Biops Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lung Cancer Liquid Biops Market Share by Type: 2024 VS 2031

Figure 4. Exosomes and RNA Features

Figure 5. CTCs and ctDNA Features

Figure 6. Global Lung Cancer Liquid Biops Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Lung Cancer Liquid Biops Market Share by Application: 2024 VS 2031

Figure 8. Hospitals and Clinics Case Studies

Figure 9. Physicians'Office Laboratories Case Studies

Figure 10. Clinical Diagnostic Laboratories Case Studies

Figure 11. Lung Cancer Liquid Biops Report Years Considered

Figure 12. Global Lung Cancer Liquid Biops Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Lung Cancer Liquid Biops Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Lung Cancer Liquid Biops Market Share by Region: 2024 VS 2031

Figure 15. Global Lung Cancer Liquid Biops Market Share by Players in 2024

Figure 16. Global Top Lung Cancer Liquid Biops Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biops Revenue in 2024

Figure 18. North America Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Lung Cancer Liquid Biops Market Share by Country (2020-2031)

Figure 20. United States Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Lung Cancer Liquid Biops Market Share by Country (2020-2031)

Figure 24. Germany Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Lung Cancer Liquid Biops Market Share by Region (2020-2031)

Figure 32. China Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Lung Cancer Liquid Biops Market Share by Country (2020-2031)

Figure 40. Mexico Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Lung Cancer Liquid Biops Market Share by Country (2020-2031)

Figure 44. Turkey Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Lung Cancer Liquid Biops Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Biocept Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 48. EntroGen Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 49. Cynvenio Biosystems Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 50. Exosome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 52. Clearbridge BioMedics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 54. Agena Bioscience Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 55. Cancer Genetics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 56. CellMax Life Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 57. Nateras Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 58. MedGenome Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 59. OncoDNA Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 60. Genomic Health Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 61. Trovagene Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 62. Fluxion Biosciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 63. Biodesix Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 64. Epic Sciences Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 65. Shuwen Biotech Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 66. Personal Genome Diagnostics Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 67. Predicine Revenue Growth Rate in Lung Cancer Liquid Biops Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Liquid Biopsy Technology Market Research Report 2025

Global Circulating Biomarker for Liquid Biopsy Market Research Report 2024

Tumor Fluid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Liquid Biopsy Tube Market Research Report 2024

Circulating Tumor Cells CTC Liquid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Cell Biopsy Service Market Research Report 2025

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Screening Software Market Research Report 2024

Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Global Liquid Biopsy Test Kit Market Research Report 2024

Lung Cancer Treatment Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Cancer Biological Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Genomic Testing Market Research Report 2024

NSCLC Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lung Cancer Diagnostic Tests Market Research Report 2024

Global Biomarkers for Signing Cancer Market Research Report 2025

Global Extracellular Vesicles Based Liquid Biopsy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions